Quantification of Smoking-Induced Occupancy of [Beta]^sub 2^-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding
5-^sup 123^I-iodo-85380 (^sup 123^I-5-IA) is used to quantitate high-affinity nicotinic acetylcholine receptors (β^sub 2^-nAChRs) on human SPECT scans. The primary outcome measure is V^sub T^/f^sub P^, the ratio at equilibrium between total tissue concentration (free, nonspecifically bound, and spec...
Gespeichert in:
Veröffentlicht in: | The Journal of nuclear medicine (1978) 2010-08, Vol.51 (8), p.1226 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 8 |
container_start_page | 1226 |
container_title | The Journal of nuclear medicine (1978) |
container_volume | 51 |
creator | Esterlis, Irina Cosgrove, Kelly P Batis, Jeffery C Bois, Frederic Stiklus, Stephanie M Perkins, Evgenia Seibyl, John P Carson, Richard E Staley, Julie K |
description | 5-^sup 123^I-iodo-85380 (^sup 123^I-5-IA) is used to quantitate high-affinity nicotinic acetylcholine receptors (β^sub 2^-nAChRs) on human SPECT scans. The primary outcome measure is V^sub T^/f^sub P^, the ratio at equilibrium between total tissue concentration (free, nonspecifically bound, and specifically bound) and the free plasma concentration. Nondisplaceable uptake (free plus nonspecific) of ^sup 123^I-5-IA has not been measured in human subjects. Nicotine has high affinity for β^sub 2^*-nAChRs (nAChRs containing the β^sub 2^* subunit, for which * represents other subunits that may also be part of the receptor) and displaces specifically bound ^sup 123^I-5-IA. In this study, we measured nicotine occupancy and nondisplaceable binding in healthy smokers after they had smoked to satiety. Methods: Eleven nicotine-dependent smokers (mean age ± SD, 35.6 ± 14.4 y) completed the study. One subject was excluded from subsequent analyses because of abnormal blood nicotine levels. Subjects abstained from tobacco smoke for 5.3 ± 0.9 d and participated in a 15- to 17-h SPECT scanning day. ^sup 123^I-5-IA was administered by bolus plus constant infusion, with a total injected dose of 361 ± 20 MBq. At approximately 6 h after the start of the infusion, three 30-min SPECT scans and a 15-min transmission-emission scan were acquired to obtain baseline β^sub 2^*-nAChR availability. Subjects then smoked to satiety (2.4 ± 0.7 cigarettes), and arterial (first 40 min) and venous (until study completion) plasma nicotine and cotinine levels were collected. About 1 h after subjects had smoked to satiety, up to six 30-min SPECT scans were acquired. V^sub T^/f^sub P^ data, computed from the tissue and plasma radioactivity measurements from the presmoking baseline and postsmoking scans, were analyzed using the Lassen plot method. Results: Receptor occupancy after subjects had smoked to satiety was 67% ± 9% (range, 55%-80%). Nondisplaceable uptake was estimated as 19.4 ± 5.8 mL*cm^sup -3^ (range. 15-28 mL*cm^sup -3^). Thus, in the thalamus, where mean V^sub T^/f^sub P^ is 93 mL*cm^sup -3^, nondisplaceable binding represents approximately 20% of the total binding. Conclusion: These results are in agreement with previous findings and suggest that when satiating doses of nicotine are administered to smokers, imaging of receptor availability can yield valuable data, such as quantifiable measures of nondisplaceable binding. [PUBLICATION ABSTRACT] |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_742470383</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2108239961</sourcerecordid><originalsourceid>FETCH-proquest_journals_7424703833</originalsourceid><addsrcrecordid>eNqNjMFOAjEURRsjiSP4D437Jh2GzkzcicHoBoKyM0LKmzf4sLyO03bBB_jfYkJcuzq5OTfnQmS5KYwyZVldikznZa6M0eZKXIew11qXdV1n4nuZLEdqCWwkz9K38vXgP4l36pmbBNjIBUDqLMPxV75NMdr3dUhbOV6rOYGPxATyHjAeHXx4R4zyBQG76PtwJ2ch0uGvPffcUOicBbRbh3JKp827kRi01gW8OXMobh9nq4cn1fX-K2GIm71PPZ_UppqMJ5Uu6qL41-kHpXBTrQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>742470383</pqid></control><display><type>article</type><title>Quantification of Smoking-Induced Occupancy of [Beta]^sub 2^-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Esterlis, Irina ; Cosgrove, Kelly P ; Batis, Jeffery C ; Bois, Frederic ; Stiklus, Stephanie M ; Perkins, Evgenia ; Seibyl, John P ; Carson, Richard E ; Staley, Julie K</creator><creatorcontrib>Esterlis, Irina ; Cosgrove, Kelly P ; Batis, Jeffery C ; Bois, Frederic ; Stiklus, Stephanie M ; Perkins, Evgenia ; Seibyl, John P ; Carson, Richard E ; Staley, Julie K</creatorcontrib><description>5-^sup 123^I-iodo-85380 (^sup 123^I-5-IA) is used to quantitate high-affinity nicotinic acetylcholine receptors (β^sub 2^-nAChRs) on human SPECT scans. The primary outcome measure is V^sub T^/f^sub P^, the ratio at equilibrium between total tissue concentration (free, nonspecifically bound, and specifically bound) and the free plasma concentration. Nondisplaceable uptake (free plus nonspecific) of ^sup 123^I-5-IA has not been measured in human subjects. Nicotine has high affinity for β^sub 2^*-nAChRs (nAChRs containing the β^sub 2^* subunit, for which * represents other subunits that may also be part of the receptor) and displaces specifically bound ^sup 123^I-5-IA. In this study, we measured nicotine occupancy and nondisplaceable binding in healthy smokers after they had smoked to satiety. Methods: Eleven nicotine-dependent smokers (mean age ± SD, 35.6 ± 14.4 y) completed the study. One subject was excluded from subsequent analyses because of abnormal blood nicotine levels. Subjects abstained from tobacco smoke for 5.3 ± 0.9 d and participated in a 15- to 17-h SPECT scanning day. ^sup 123^I-5-IA was administered by bolus plus constant infusion, with a total injected dose of 361 ± 20 MBq. At approximately 6 h after the start of the infusion, three 30-min SPECT scans and a 15-min transmission-emission scan were acquired to obtain baseline β^sub 2^*-nAChR availability. Subjects then smoked to satiety (2.4 ± 0.7 cigarettes), and arterial (first 40 min) and venous (until study completion) plasma nicotine and cotinine levels were collected. About 1 h after subjects had smoked to satiety, up to six 30-min SPECT scans were acquired. V^sub T^/f^sub P^ data, computed from the tissue and plasma radioactivity measurements from the presmoking baseline and postsmoking scans, were analyzed using the Lassen plot method. Results: Receptor occupancy after subjects had smoked to satiety was 67% ± 9% (range, 55%-80%). Nondisplaceable uptake was estimated as 19.4 ± 5.8 mL*cm^sup -3^ (range. 15-28 mL*cm^sup -3^). Thus, in the thalamus, where mean V^sub T^/f^sub P^ is 93 mL*cm^sup -3^, nondisplaceable binding represents approximately 20% of the total binding. Conclusion: These results are in agreement with previous findings and suggest that when satiating doses of nicotine are administered to smokers, imaging of receptor availability can yield valuable data, such as quantifiable measures of nondisplaceable binding. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 1535-5667</identifier><identifier>CODEN: JNMEAQ</identifier><language>eng</language><publisher>New York: Society of Nuclear Medicine</publisher><subject>Behavior ; Brain ; Medical imaging ; Studies</subject><ispartof>The Journal of nuclear medicine (1978), 2010-08, Vol.51 (8), p.1226</ispartof><rights>Copyright Society of Nuclear Medicine Aug 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Esterlis, Irina</creatorcontrib><creatorcontrib>Cosgrove, Kelly P</creatorcontrib><creatorcontrib>Batis, Jeffery C</creatorcontrib><creatorcontrib>Bois, Frederic</creatorcontrib><creatorcontrib>Stiklus, Stephanie M</creatorcontrib><creatorcontrib>Perkins, Evgenia</creatorcontrib><creatorcontrib>Seibyl, John P</creatorcontrib><creatorcontrib>Carson, Richard E</creatorcontrib><creatorcontrib>Staley, Julie K</creatorcontrib><title>Quantification of Smoking-Induced Occupancy of [Beta]^sub 2^-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding</title><title>The Journal of nuclear medicine (1978)</title><description>5-^sup 123^I-iodo-85380 (^sup 123^I-5-IA) is used to quantitate high-affinity nicotinic acetylcholine receptors (β^sub 2^-nAChRs) on human SPECT scans. The primary outcome measure is V^sub T^/f^sub P^, the ratio at equilibrium between total tissue concentration (free, nonspecifically bound, and specifically bound) and the free plasma concentration. Nondisplaceable uptake (free plus nonspecific) of ^sup 123^I-5-IA has not been measured in human subjects. Nicotine has high affinity for β^sub 2^*-nAChRs (nAChRs containing the β^sub 2^* subunit, for which * represents other subunits that may also be part of the receptor) and displaces specifically bound ^sup 123^I-5-IA. In this study, we measured nicotine occupancy and nondisplaceable binding in healthy smokers after they had smoked to satiety. Methods: Eleven nicotine-dependent smokers (mean age ± SD, 35.6 ± 14.4 y) completed the study. One subject was excluded from subsequent analyses because of abnormal blood nicotine levels. Subjects abstained from tobacco smoke for 5.3 ± 0.9 d and participated in a 15- to 17-h SPECT scanning day. ^sup 123^I-5-IA was administered by bolus plus constant infusion, with a total injected dose of 361 ± 20 MBq. At approximately 6 h after the start of the infusion, three 30-min SPECT scans and a 15-min transmission-emission scan were acquired to obtain baseline β^sub 2^*-nAChR availability. Subjects then smoked to satiety (2.4 ± 0.7 cigarettes), and arterial (first 40 min) and venous (until study completion) plasma nicotine and cotinine levels were collected. About 1 h after subjects had smoked to satiety, up to six 30-min SPECT scans were acquired. V^sub T^/f^sub P^ data, computed from the tissue and plasma radioactivity measurements from the presmoking baseline and postsmoking scans, were analyzed using the Lassen plot method. Results: Receptor occupancy after subjects had smoked to satiety was 67% ± 9% (range, 55%-80%). Nondisplaceable uptake was estimated as 19.4 ± 5.8 mL*cm^sup -3^ (range. 15-28 mL*cm^sup -3^). Thus, in the thalamus, where mean V^sub T^/f^sub P^ is 93 mL*cm^sup -3^, nondisplaceable binding represents approximately 20% of the total binding. Conclusion: These results are in agreement with previous findings and suggest that when satiating doses of nicotine are administered to smokers, imaging of receptor availability can yield valuable data, such as quantifiable measures of nondisplaceable binding. [PUBLICATION ABSTRACT]</description><subject>Behavior</subject><subject>Brain</subject><subject>Medical imaging</subject><subject>Studies</subject><issn>0161-5505</issn><issn>1535-5667</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNjMFOAjEURRsjiSP4D437Jh2GzkzcicHoBoKyM0LKmzf4sLyO03bBB_jfYkJcuzq5OTfnQmS5KYwyZVldikznZa6M0eZKXIew11qXdV1n4nuZLEdqCWwkz9K38vXgP4l36pmbBNjIBUDqLMPxV75NMdr3dUhbOV6rOYGPxATyHjAeHXx4R4zyBQG76PtwJ2ch0uGvPffcUOicBbRbh3JKp827kRi01gW8OXMobh9nq4cn1fX-K2GIm71PPZ_UppqMJ5Uu6qL41-kHpXBTrQ</recordid><startdate>20100801</startdate><enddate>20100801</enddate><creator>Esterlis, Irina</creator><creator>Cosgrove, Kelly P</creator><creator>Batis, Jeffery C</creator><creator>Bois, Frederic</creator><creator>Stiklus, Stephanie M</creator><creator>Perkins, Evgenia</creator><creator>Seibyl, John P</creator><creator>Carson, Richard E</creator><creator>Staley, Julie K</creator><general>Society of Nuclear Medicine</general><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20100801</creationdate><title>Quantification of Smoking-Induced Occupancy of [Beta]^sub 2^-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding</title><author>Esterlis, Irina ; Cosgrove, Kelly P ; Batis, Jeffery C ; Bois, Frederic ; Stiklus, Stephanie M ; Perkins, Evgenia ; Seibyl, John P ; Carson, Richard E ; Staley, Julie K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_7424703833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Behavior</topic><topic>Brain</topic><topic>Medical imaging</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Esterlis, Irina</creatorcontrib><creatorcontrib>Cosgrove, Kelly P</creatorcontrib><creatorcontrib>Batis, Jeffery C</creatorcontrib><creatorcontrib>Bois, Frederic</creatorcontrib><creatorcontrib>Stiklus, Stephanie M</creatorcontrib><creatorcontrib>Perkins, Evgenia</creatorcontrib><creatorcontrib>Seibyl, John P</creatorcontrib><creatorcontrib>Carson, Richard E</creatorcontrib><creatorcontrib>Staley, Julie K</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>The Journal of nuclear medicine (1978)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Esterlis, Irina</au><au>Cosgrove, Kelly P</au><au>Batis, Jeffery C</au><au>Bois, Frederic</au><au>Stiklus, Stephanie M</au><au>Perkins, Evgenia</au><au>Seibyl, John P</au><au>Carson, Richard E</au><au>Staley, Julie K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantification of Smoking-Induced Occupancy of [Beta]^sub 2^-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding</atitle><jtitle>The Journal of nuclear medicine (1978)</jtitle><date>2010-08-01</date><risdate>2010</risdate><volume>51</volume><issue>8</issue><spage>1226</spage><pages>1226-</pages><issn>0161-5505</issn><eissn>1535-5667</eissn><coden>JNMEAQ</coden><abstract>5-^sup 123^I-iodo-85380 (^sup 123^I-5-IA) is used to quantitate high-affinity nicotinic acetylcholine receptors (β^sub 2^-nAChRs) on human SPECT scans. The primary outcome measure is V^sub T^/f^sub P^, the ratio at equilibrium between total tissue concentration (free, nonspecifically bound, and specifically bound) and the free plasma concentration. Nondisplaceable uptake (free plus nonspecific) of ^sup 123^I-5-IA has not been measured in human subjects. Nicotine has high affinity for β^sub 2^*-nAChRs (nAChRs containing the β^sub 2^* subunit, for which * represents other subunits that may also be part of the receptor) and displaces specifically bound ^sup 123^I-5-IA. In this study, we measured nicotine occupancy and nondisplaceable binding in healthy smokers after they had smoked to satiety. Methods: Eleven nicotine-dependent smokers (mean age ± SD, 35.6 ± 14.4 y) completed the study. One subject was excluded from subsequent analyses because of abnormal blood nicotine levels. Subjects abstained from tobacco smoke for 5.3 ± 0.9 d and participated in a 15- to 17-h SPECT scanning day. ^sup 123^I-5-IA was administered by bolus plus constant infusion, with a total injected dose of 361 ± 20 MBq. At approximately 6 h after the start of the infusion, three 30-min SPECT scans and a 15-min transmission-emission scan were acquired to obtain baseline β^sub 2^*-nAChR availability. Subjects then smoked to satiety (2.4 ± 0.7 cigarettes), and arterial (first 40 min) and venous (until study completion) plasma nicotine and cotinine levels were collected. About 1 h after subjects had smoked to satiety, up to six 30-min SPECT scans were acquired. V^sub T^/f^sub P^ data, computed from the tissue and plasma radioactivity measurements from the presmoking baseline and postsmoking scans, were analyzed using the Lassen plot method. Results: Receptor occupancy after subjects had smoked to satiety was 67% ± 9% (range, 55%-80%). Nondisplaceable uptake was estimated as 19.4 ± 5.8 mL*cm^sup -3^ (range. 15-28 mL*cm^sup -3^). Thus, in the thalamus, where mean V^sub T^/f^sub P^ is 93 mL*cm^sup -3^, nondisplaceable binding represents approximately 20% of the total binding. Conclusion: These results are in agreement with previous findings and suggest that when satiating doses of nicotine are administered to smokers, imaging of receptor availability can yield valuable data, such as quantifiable measures of nondisplaceable binding. [PUBLICATION ABSTRACT]</abstract><cop>New York</cop><pub>Society of Nuclear Medicine</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-5505 |
ispartof | The Journal of nuclear medicine (1978), 2010-08, Vol.51 (8), p.1226 |
issn | 0161-5505 1535-5667 |
language | eng |
recordid | cdi_proquest_journals_742470383 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Behavior Brain Medical imaging Studies |
title | Quantification of Smoking-Induced Occupancy of [Beta]^sub 2^-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T02%3A34%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantification%20of%20Smoking-Induced%20Occupancy%20of%20%5BBeta%5D%5Esub%202%5E-Nicotinic%20Acetylcholine%20Receptors:%20Estimation%20of%20Nondisplaceable%20Binding&rft.jtitle=The%20Journal%20of%20nuclear%20medicine%20(1978)&rft.au=Esterlis,%20Irina&rft.date=2010-08-01&rft.volume=51&rft.issue=8&rft.spage=1226&rft.pages=1226-&rft.issn=0161-5505&rft.eissn=1535-5667&rft.coden=JNMEAQ&rft_id=info:doi/&rft_dat=%3Cproquest%3E2108239961%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=742470383&rft_id=info:pmid/&rfr_iscdi=true |